Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

31 Oct 2018 12:02

RNS Number : 8883F
GlaxoSmithKline PLC
31 October 2018
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PMELFLFXVBFBFBL
Date   Source Headline
7th Sep 20182:18 pmRNSDirector/PDMR Shareholding
3rd Sep 20185:00 pmRNSTotal Voting Rights
30th Aug 20185:12 pmRNSGSK publishes Q4 2018 Dividend Dates
30th Aug 20188:12 amRNSEU approve Nucala in severe asthma in children
24th Aug 201810:16 amRNSDirector/PDMR Shareholding
15th Aug 20187:00 amRNSPositive headline results for ViiV HC ATLAS study
10th Aug 20183:00 pmRNSDirector/PDMR Shareholding
8th Aug 201812:35 pmRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSIain Mackay appointed GSK Chief Financial Officer
2nd Aug 20185:07 pmRNSPublication of Base Prospectus
2nd Aug 201811:04 amRNSTotal Voting Rights
31st Jul 20185:03 pmRNSDirector/PDMR Shareholding
31st Jul 20184:37 pmRNSDirector/PDMR Shareholding
27th Jul 20184:30 pmRNSDirector/PDMR Shareholding
27th Jul 20182:47 pmRNSCHMP recommend Nucala for severe asthma children
26th Jul 20187:00 amRNSGSK reports on FDA Ad Com on mepolizumab for COPD
25th Jul 20184:15 pmRNSDirector/PDMR Shareholding
25th Jul 201811:00 amRNSGSK and 23andMe Agreement
25th Jul 201811:00 amRNS2nd Quarter Results
24th Jul 20189:01 amRNSViiV announces Juluca 100 week data at AIDS 2018
24th Jul 20189:00 amRNSViiV shows positive phIII data on two-drug combo
19th Jul 20184:45 pmRNSDirector/PDMR Shareholding
17th Jul 20185:46 pmRNSDirector/PDMR Shareholding
17th Jul 20184:54 pmRNSDirector/PDMR Shareholding
17th Jul 20184:49 pmRNSDirector/PDMR Shareholding
16th Jul 20182:51 pmRNSDirector/PDMR Shareholding
16th Jul 201811:11 amRNSDirector/PDMR Shareholding
13th Jul 20184:16 pmRNSDirector/PDMR Shareholding
13th Jul 20184:16 pmRNSDirector/PDMR Shareholding
11th Jul 20182:42 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:30 pmRNSTotal Voting Rights
14th Jun 20187:00 amRNSPositive headline results for ViiV GEMINI studies
12th Jun 20185:15 pmRNSDirector/PDMR Shareholding
12th Jun 20182:00 pmRNSGSK announces changes to Corporate Executive Team
1st Jun 20181:00 pmRNSGSK completes Consumer Healthcare buyout
1st Jun 20189:42 amRNSTotal Voting Rights
29th May 20187:00 amRNSGSK Once-daily single inhaler triple therapy COPD
21st May 201811:02 amRNSViiV granted EU marketing authorisation for Juluca
15th May 20181:39 pmRNSDirector/PDMR Shareholding
11th May 20183:17 pmRNSDirector/PDMR Shareholding
10th May 20185:20 pmRNSBlock listing Interim Review
9th May 20185:05 pmRNSDirector/PDMR Shareholding - replacement
9th May 201812:00 pmRNSDirectorate Change
3rd May 20186:31 pmRNSResult of General Meeting
3rd May 20186:29 pmRNSResult of AGM
1st May 20182:45 pmRNSTotal Voting Rights
27th Apr 201812:43 pmRNSDirector/PDMR Shareholding
26th Apr 20183:30 pmRNSDirector/PDMR Shareholding
25th Apr 201812:07 pmRNSSecond Price Monitoring Extn
25th Apr 201812:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.